logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
I

Ildiko Lingvay

ut southwestern medical center

86H-index
447Paper Count
4.2WCitation Count
Published Papers 197
Publication Date
logo
Association of GLP1 ‐Receptor Agonist Use With Frailty and Falls in Adults With Type 2 Diabetes
errDIABETES OBESITY & METABOLISM
IF5.7
err2026-10-07
err0
PREAI
errShuyao Zhang; Ildiko Lingvay; Ishak Mansi
errShare
errSave
Semaglutide and cardiovascular risk reduction: a mediation analysis of the SELECT trial
errEuropean Heart Journal
IF35.6
err2026-09-23
err0
errOAAI
errHelen M Colhoun; A Michael Lincoff; Donna Ryan; Ildiko Lingvay; Steven E Kahn; G Kees Hovingh; Søren Hardt-Lindberg; Tugce Kalayci Oral; Peter E Weeke; Martin Linder; Ales Linhart; Bartolome Burguera; André P van Beek; Jose Francisco Kerr Saraiva; Yaron Arbel; Scott S Emerson; Jorge Plutzky; John Deanfield
errShare
errSave
Effect of Semaglutide on Thigh Skeletal Muscle Volume, Fat Infiltration and Physical Function in People With Obesity: Secondary Analysis of STEP UP
errDIABETES OBESITY & METABOLISM
IF5.7
err2026-09-21
err0
errOAAI
errJøran Hjelmesæth; Suhas Bhat; W. Timothy Garvey; Kristoffer Jensen Kolnes; Jennifer Linge; Ildiko Lingvay; Niklas Kahr Rasmussen; Julio Rosenstock; Sean Wharton
errShare
errSave
B cell mechanisms underlie IgG glycan alterations in obesity
errGlycobiology
IF3.3
err2026-08-29
err0
errOAAI
errJun Peng; Ming Yang; Anika Mijakovac; Ken L Chambliss; Md Nurul Islam; Tamara Štambuk; Domagoj Kifer; Kenian Chen; Iwona Borošak; Helena Deriš; Kristina Nikolić Prpić; Nancy Monson; Ildiko Lingvay; Olga T Gupta; Vlatka Zoldoš; Gordan Lauc; Jacob Hartz; Lin Xu; Chieko Mineo; Philip W Shaul; null
errShare
errSave
Regional and national trends in prescription of guideline directed cardio-kidney protective medications in people with type 2 diabetes and cardio-kidney disease
errPrimary Care Diabetes
IF2.3
err2026-08-04
err0
PREAI
errShubham Agarwal; Mujeeb A. Basit; Kelsea Marble; Christine Mai; Michael E. Bowen; Jonathan Pak; Yaser ElNakieb; Ildiko Lingvay
errShare
errSave
Publisher Correction: Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial
errNature Medicine
IF50
err2026-06-24
err0
errOAAI
errJulio Rosenstock; Ildiko Lingvay; Donna Ryan; Ania M. Jastreboff; Robert Kushner; Andres Acosta; Thomas C. Blevins; Melissa Choi; Faith L. Holmes; Timothy Smith; Lisa Connery; Yao Li; Mike Ke Liu; Aline Barth; Jamie Butcher; Antonio Civitarese; Huibin Yue; Blai Coll
errShare
errSave
Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity: a randomized, double-blind, placebo-controlled phase 2b trial
errNature Medicine
IF50
err2026-06-05
err0
errOAAI
errJulio Rosenstock; Ildiko Lingvay; Donna Ryan; Ania M. Jastreboff; Robert Kushner; Andres Acosta; Thomas C. Blevins; Melissa Choi; Faith L. Holmes; Timothy Smith; Lisa Connery; Yao Li; Mike Ke Liu; Aline Barth; Jamie Butcher; Antonio Civitarese; Huibin Yue; Blai Coll
errShare
errSave
Designing Next-Generation Cardiometabolic Outcome Trials for Obesity Medicines
errJACC
IF0
err2026-04-21
err0
PREAI
errElke Platz; Alexander Peikert; Biykem Bozkurt; Bart Van der Schueren; Javed Butler; Ildiko Lingvay; Darren K. McGuire; Faiez Zannad; Naveed Sattar
errShare
errSave
Hyperaldosteronism in the Pathophysiology and Management of Cardiovascular-Kidney-Metabolic Syndrome
errdiabetes, obesity and metabolism
IF0
err2026-04-20
err0
errOAAI
errEvan Zeitler; Klara R. Klein; Ildiko Lingvay; Anthony Pick; Liana K. Billings
errShare
errSave
Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trial
errNature Medicine
IF50
err2026-04-02
err0
errOAAI
errSebastian M. Meyhöfer; Bertrand Cariou; Cintia Cercato; Helen M. Colhoun; John Deanfield; Michelle T. Long; Ole Kleist Jeppesen; A. Michael Lincoff; Ildiko Lingvay; Jorge Plutzky; Philip N. Newsome; Stephen J. Nicholls; Maria Quiroga; Ferruccio Santini; Arun J. Sanyal; Steven E. Kahn
errShare
errSave
Comparing survey delivery methods in healthcare: A randomized study
errJournal of Clinical and Translational Science
IF2
err2025-11-17
err0
errOAAI
errTumyan, Gayane; Esselink, Kathleen; Navar, Ann Marie; Lingvay, Ildiko
errShare
errSave
Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial
errThe Lancet
IF97.3
err2025-10-22
err0
errOAAI
errJohn Deanfield; A Michael Lincoff; Steven E Kahn; Scott S Emerson; Ildiko Lingvay; Benjamin M Scirica; Jorge Plutzky; Robert F Kushner; Helen M Colhoun; G Kees Hovingh; Signe Stensen; Peter E Weeke; Ole Kleist Jeppesen; Rafael Bravo; Chau-Chung Wu; Issei Komuro; Ferruccio Santini; Jøran Hjelmesæth; Miguel Urina-Triana; Silvio Buscemi; Donna H Ryan
errShare
errSave
Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity
errNEW ENGLAND JOURNAL OF MEDICINE
IF78.5
err2025-09-18
err4
PREAI
errWharton, Sean; Lingvay, Ildiko; Bogdanski, Pawel; Duque do Vale, Ruben; Jacob, Stephan; Karlsson, Tobias; Shaji, Chaithra; Rubino, Domenica; Garvey, W. Timothy
errShare
errSave
Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial
errThe Lancet Diabetes & Endocrinology
IF0
err2025-09-14
err0
PREAI
errSean Wharton; Paula Freitas; Jøran Hjelmesæth; Maria Kabisch; Kristian Kandler; Ildiko Lingvay; Maria Quiroga; Julio Rosenstock; W Timothy Garvey
errShare
errSave
Once-weekly semaglutide 7·2 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial
errThe Lancet Diabetes & Endocrinology
IF0
err2025-09-14
err0
PREAI
errIldiko Lingvay; Sara J Bergenheim; John B Buse; Paula Freitas; W Timothy Garvey; Nina M Harder-Lauridsen; Julio Rosenstock; Kushal Sahu; Sean Wharton
errShare
errSave
Use of commercially available automated insulin delivery systems in pregnant people with type 1 diabetes
errDiabetes Research and Clinical Practice
IF7.4
err2025-09-01
err0
PREAI
errAngela Q. Pham; Ildiko Lingvay; Nicole Ahmadi; Patricia C. Santiago-Munoz; Marconi Abreu
errShare
errSave
Adherence to app-based dose guidance for once-weekly insulin icodec in insulin-naive individuals with type 2 diabetes: Post hoc analysis of ONWARDS 5
errdiabetes obesity metabolism
IF0
err2025-08-13
err0
PREAI
errHarpreet S. Bajaj MD; Lars Villads Bennedsen MD; Anders Meller Donatsky MD; Johannes Handberg Juul Martiny PhD; André Vianna MD; Ildiko Lingvay MD
errShare
errSave
Clinical Use of Once-Weekly Insulin Icodec: Translating Clinical Trial Data into Practical Guidance for Diabetes Management
errDrugs
IF14.4
err2025-08-13
err0
errOAAI
errAthena Philis-Tsimikas; Jens Aberle; Harpreet Bajaj; Ildiko Lingvay; Yiming Mu; Shehla Shaikh; André Vianna; Hirotaka Watada; Stefano Del Prato
errShare
errSave
Association of GLP1-receptor agonist use with liver disease progression, major cardiovascular events, and mortality in people with hepatic steatosis and diabetes
errdiabetes obesity metabolism
IF0
err2025-07-30
err0
PREAI
errSuleiman Al Ashi MD; Raj Shah MD; Nofel Iftikhar BA; Ildiko Lingvay MD; Mustafa Kinaan MD; Ishak A. Mansi MD
errShare
errSave
Author's response to the Letter to the Editor “Glucagon-like Peptide-1 receptor agonists versus dipeptidyl-peptidase 4 inhibitors in advanced chronic kidney disease and end stage kidney disease: Real world effectiveness and persistence of therapy”
errJournal of Diabetes and its Complications
IF3.1
err2025-07-25
err0
PREAI
errShubham Agarwal; F.N.U. Sidra; Ildiko Lingvay
errShare
errSave

Research Directions

The data has not been retrieved yet.
Co-authors
Cooperation Journals
A
Arun J. Sanyal
H-index: 166 · Papers: 1.4K
K
Kamlesh Khunti
H-index: 162 · Papers: 2.1K
C
Christopher B. Granger
H-index: 155 · Papers: 1.4K
T
Takashi Kadowaki
H-index: 153 · Papers: 1.4K
J
John A. Spertus
H-index: 151 · Papers: 2.0K
View more